These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 9443474)

  • 1. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype.
    Craft S; Peskind E; Schwartz MW; Schellenberg GD; Raskind M; Porte D
    Neurology; 1998 Jan; 50(1):164-8. PubMed ID: 9443474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotype.
    Craft S; Asthana S; Cook DG; Baker LD; Cherrier M; Purganan K; Wait C; Petrova A; Latendresse S; Watson GS; Newcomer JW; Schellenberg GD; Krohn AJ
    Psychoneuroendocrinology; 2003 Aug; 28(6):809-22. PubMed ID: 12812866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease.
    Craft S; Teri L; Edland SD; Kukull WA; Schellenberg G; McCormick WC; Bowen JD; Larson EB
    Neurology; 1998 Jul; 51(1):149-53. PubMed ID: 9674794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype.
    Fagan AM; Younkin LH; Morris JC; Fryer JD; Cole TG; Younkin SG; Holtzman DM
    Ann Neurol; 2000 Aug; 48(2):201-10. PubMed ID: 10939571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype.
    Craft S; Asthana S; Schellenberg G; Baker L; Cherrier M; Boyt AA; Martins RN; Raskind M; Peskind E; Plymate S
    Ann N Y Acad Sci; 2000 Apr; 903():222-8. PubMed ID: 10818510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin metabolism in Alzheimer's disease differs according to apolipoprotein E genotype and gender.
    Craft S; Asthana S; Schellenberg G; Cherrier M; Baker LD; Newcomer J; Plymate S; Latendresse S; Petrova A; Raskind M; Peskind E; Lofgreen C; Grimwood K
    Neuroendocrinology; 1999 Aug; 70(2):146-52. PubMed ID: 10461029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.
    Johansson P; Almqvist EG; Bjerke M; Wallin A; Johansson JO; Andreasson U; Blennow K; Zetterberg H; Svensson J
    J Alzheimers Dis; 2017; 59(3):1017-1026. PubMed ID: 28697566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
    Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
    Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau protein in cerebrospinal fluid from semantic dementia patients.
    Andersen C; Froelich Fabre S; Ostberg P; Lannfelt L; Wahlund L
    Neurosci Lett; 2000 Nov; 294(3):155-8. PubMed ID: 11072138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF tau is related to apolipoprotein E genotype in early Alzheimer's disease.
    Tapiola T; Lehtovirta M; Ramberg J; Helisalmi S; Linnaranta K; Riekkinen P; Soininen H
    Neurology; 1998 Jan; 50(1):169-74. PubMed ID: 9443475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer's Disease.
    Geijselaers SLC; Aalten P; Ramakers IHGB; De Deyn PP; Heijboer AC; Koek HL; OldeRikkert MGM; Papma JM; Reesink FE; Smits LL; Stehouwer CDA; Teunissen CE; Verhey FRJ; van der Flier WM; Biessels GJ;
    J Alzheimers Dis; 2018; 61(1):309-320. PubMed ID: 29154275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype.
    Liu RY; Zhou JN; van Heerikhuize J; Hofman MA; Swaab DF
    J Clin Endocrinol Metab; 1999 Jan; 84(1):323-7. PubMed ID: 9920102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease.
    Patra K; Soosaipillai A; Sando SB; Lauridsen C; Berge G; Møller I; Grøntvedt GR; Bråthen G; Begcevic I; Moussaud S; Minthon L; Hansson O; Diamandis EP; White LR; Nielsen HM
    Alzheimers Res Ther; 2018 Jan; 10(1):9. PubMed ID: 29378650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study.
    Cysique LA; Hewitt T; Croitoru-Lamoury J; Taddei K; Martins RN; Chew CS; Davies NN; Price P; Brew BJ
    BMC Neurol; 2015 Apr; 15():51. PubMed ID: 25880550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects. Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions.
    Skoog I; Hesse C; Fredman P; Andreasson LA; Palmertz B; Blennow K
    Arch Neurol; 1997 Mar; 54(3):267-72. PubMed ID: 9074395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid levels of amyloid beta-protein in Alzheimer's disease: inverse correlation with severity of dementia and effect of apolipoprotein E genotype.
    Nitsch RM; Rebeck GW; Deng M; Richardson UI; Tennis M; Schenk DB; Vigo-Pelfrey C; Lieberburg I; Wurtman RJ; Hyman BT
    Ann Neurol; 1995 Apr; 37(4):512-8. PubMed ID: 7717688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer's disease patients.
    Gabriel AJ; Almeida MR; Ribeiro MH; Durães J; Tábuas-Pereira M; Pinheiro AC; Pascoal R; Santana I; Baldeiras I
    Neurosci Lett; 2017 Feb; 641():101-106. PubMed ID: 28108398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.